Courtney Travis
Family · Farragut, TNNPI 1376910166
Payments from drug & device makers
Across 136 payments — averaging $16.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Collegium Pharmaceutical, Inc.$488
- Scilex Pharmaceuticals Inc.$407
- Curonix LLC$204
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$202
- Biodelivery Sciences International, Inc.$175
- Boston Scientific$89
- plus $704 from 19 others
What the payments were for
- Food & beverage$2,270100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 40 | $488 |
| Scilex Pharmaceuticals Inc. | 25 | $407 |
| Curonix LLC | 5 | $204 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $202 |
| Biodelivery Sciences International, Inc. | 15 | $175 |
| Boston Scientific | 2 | $89 |
| Redhill Biopharma Inc. | 5 | $78 |
| Medtronic | 4 | $67 |
| Virtus Pharmaceuticals LLC | 3 | $57 |
| Amneal Pharmaceuticals LLC | 2 | $53 |
| Sanofi | 2 | $52 |
| Azurity Pharmaceuticals, Inc. | 3 | $49 |
| Fidia Pharma USA Inc. | 2 | $47 |
| Arbor Pharmaceuticals, Inc. | 3 | $43 |
| Vertos Medical, Inc. | 2 | $39 |
| Saluda Medical Americas, Inc. | 2 | $31 |
| Averitas Pharma Inc. | 1 | $30 |
| Tonix Medicines, Inc. | 1 | $29 |
| Daiichi Sankyo Inc. | 1 | $28 |
| Vertex | 1 | $21 |
| Stimwave Technologies Incorporated | 1 | $19 |
| Ultragenyx Pharmaceutical Inc. | 1 | $19 |
| GRT US Holding, Inc. | 1 | $15 |
| Almatica Pharma LLC | 1 | $14 |
| Pfizer | 1 | $14 |
How this compares
$2,270 in reported general payments places this provider in the 75th percentile of 6,706 family providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 780 | $25,142 |
| BelbucaBuprenorphine Hcl | 40 | $22,666 |
| Diclofenac Potassium | 30 | $20,255 |
| Xtampza ErOxycodone Myristate | 57 | $18,679 |
| ZtlidoLidocaine | 16 | $16,298 |
| LinzessLinaclotide | 23 | $14,820 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 526 | $13,298 |
| MovantikNaloxegol Oxalate | 23 | $10,141 |
| Gabapentin | 575 | $7,540 |
| Buprenorphine | 36 | $6,425 |
| Oxycodone Hcl | 273 | $4,496 |
| Lidocaine | 35 | $3,698 |
| Morphine Sulfate ErMorphine Sulfate | 140 | $2,959 |
| Tizanidine Hcl | 220 | $2,413 |
| Cyclobenzaprine Hcl | 177 | $1,717 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $488 | $41,34597 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $407 | $16,29816 claims |
| Redhill Biopharma Inc.Movantik | $78 | $10,14123 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,706 family providers in Tennessee.
Other family in Farragut
- Stacy BrownMt Juliet$719K
- Dana WebberKnoxville$499K
- Brandy BiedermanHixson$448K
- Cynthia MillerMurfreesboro$384K
- Tamera ThoenerNashville$254K
- April SwonerHermitage$246K
- Jennifer WilliamsNashville$213K
- Chantil JeffreysGermantown$195K
- Laura PorchCordova$148K
- Lori LankfordNashville$148K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.